New Treatment Approach for Difficult High Blood Pressure
TL;DR
AstraZeneca's experimental drug Baxdrostat shows promise in treating resistant high blood pressure, potentially offering a new approach for patients unresponsive to existing medications, with significant blood pressure reductions observed in a recent trial.
Topics:top-newshealth#astrazeneca#baxdrostat#cardiovascular-risk#health#high-blood-pressure#hypertension-treatment
Want the full story? Read the original reporting
Read on Yahoo News Singapore